Magnolioside
CAS: 20186-29-2
Ref. 3D-VAA18629
| 5mg | Nachfragen | ||
| 10mg | Nachfragen | ||
| 25mg | Nachfragen | ||
| 50mg | Nachfragen | ||
| 100mg | Nachfragen |
Produktinformation
- 2H-1-Benzopyran-2-one, 6-(b-D-glucopyranosyloxy)-7-methoxy-
- 2H-1-Benzopyran-2-one, 6-(beta-D-glucopyranosyloxy)-7-methoxy-
Magnolioside is a bioactive compound that has been shown to have potent anti-inflammatory effects. It has been shown to inhibit the production of pro-inflammatory cytokines, such as tumor necrosis factor (TNF) and interleukin-1β (IL-1β), by inhibiting the activation of nuclear factor kappa B (NFκB). Magnolioside also inhibits the production of cyclooxygenase-2 (COX-2) and reduces the production of prostaglandins. This compound also has neuroprotective effects and was found to be effective against radiation-induced cognitive impairment in rats. Magnolioside is cytotoxic to cancer cells, including colorectal cancer cell lines, and may be a potential anticancer agent for colon cancer. The mechanism by which Magnolioside exerts its cytotoxic effect on cancer cells is not well understood; however, it may involve modulation of cellular signaling pathways or inhibition of
Chemische Eigenschaften
Technische Anfrage zu: 3D-VAA18629 Magnolioside
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
